Home Cart 0 Sign in  
X

[ CAS No. 18085-37-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 18085-37-5
Chemical Structure| 18085-37-5
Chemical Structure| 18085-37-5
Structure of 18085-37-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 18085-37-5 ]

Related Doc. of [ 18085-37-5 ]

Alternatived Products of [ 18085-37-5 ]

Product Details of [ 18085-37-5 ]

CAS No. :18085-37-5 MDL No. :MFCD06657098
Formula : C12H15NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :CTFFWKWHYDAMKP-UHFFFAOYSA-N
M.W : 205.25 Pubchem ID :4385248
Synonyms :

Calculated chemistry of [ 18085-37-5 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.42
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 61.43
TPSA : 29.54 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.44
Log Po/w (XLOGP3) : 1.84
Log Po/w (WLOGP) : 0.9
Log Po/w (MLOGP) : 1.59
Log Po/w (SILICOS-IT) : 1.85
Consensus Log Po/w : 1.72

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.3
Solubility : 1.02 mg/ml ; 0.00497 mol/l
Class : Soluble
Log S (Ali) : -2.08
Solubility : 1.7 mg/ml ; 0.0083 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.82
Solubility : 0.311 mg/ml ; 0.00151 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.91

Safety of [ 18085-37-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 18085-37-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 18085-37-5 ]
  • Downstream synthetic route of [ 18085-37-5 ]

[ 18085-37-5 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 29547-04-4 ]
  • [ 100-46-9 ]
  • [ 18085-37-5 ]
YieldReaction ConditionsOperation in experiment
67% With triethylamine In acetonitrile for 4 h; Reflux To a solution of methyl 1,3-dibromopropionate (7.8 mL, 55.2 mmol, 1 equiv) in CH3CN (120 mL), were added NEt3 (23 mL, 166 mmol, 3 equiv) and benzylamine (6 mL, 55.2 mmol, 1 equiv). The solution was heated to reflux and stirred for 4 h. After cooling, water (70 mL) was added and the product was extracted with Et2O (3.x.40 mL). The combined organic layer was dried over MgSO4, filtered and concentrated under reduced pressure. The crude product was purified by flash chromatography (AcOEt/petroleum ether, 1:7 to 2:1) to afford azetidine 4 (7.58 g, 67percent) as an orange oil. TLC Rf 0.21 (silica gel, AcOEt/petroleum ether, 1:3); 1H NMR (300 MHz, CDCl3) δ 7.33-7.17 (m, 5H, Ph), 3.78 (d, 1H, J=12.6 Hz, CH2Ph), 3.71 (t, 1H, J=8.4 Hz, H-1), 3.60 (s, 3H, CO2Me), 3.56 (d, 1H, J=12.6 Hz, CH2Ph), 3.29 (m, 1H, H-4a), 2.91 (m, 1H, H-4b), 2.34 (m, 1H, H-3a), 2.18 (m, 1H, H-3b). Spectroscopic data are in accordance with literature data.26
26%
Stage #1: With triethylamine In methanol at 0℃; for 0.166667 h;
Stage #2: at 20℃;
A solution of methyl 2,4-dibromobutanoate 20 (10.01 g, 38.49 mmol, 1.0 eq.) in methanol (15 ml) was added drop-wise to a stirred solution of triethylamine (11.68 g, 16.01 ml, 115.5 mmol, 3.0 eq.) in methanol (40 ml) at 0 °C. The solution was stirred for 15 min after which time benzylamine (4.33 g, 4.41 ml, 40.4 mmol, 1.05 eq.) in methanol (25 ml) was added in a drop-wise manner and stirring was continued for a further 30 min after which time the solutionwas left to warm to rt and finally left to stir overnight. The reaction mixture was concentrated in vacuo and then diluted with diethylether (100 ml). The resulting solids were removed by filtration. The organic phase was washed with water (200 ml) and the aqueous phase was extracted with diethyl ether (3 50 ml). The combinedorganic phases were dried (Na2SO4), filtered and evaporated invacuo. The crude material was purified by column chromatography(25percent ethyl acetate: hexane) to afford methyl 1-benzylazetidine-2-carboxylate 21 as an orange oil (2.02 g, 26percent). Rf 0.35 (1:3 ethylacetate: hexane); νmax (neat)/cm-1 2953, 2837, 1737, 1442, 1201,1172; 1H NMR (300 MHz, CDCl3); δ 7.35e7.17 (m, 5H, ArH's),3.84e3.70 (m, 2H, CH2Ph), 3.62 (s, 3H, OCH3), 3.58 (d, 1H,J 12.5 Hz, COCH), 3.35e3.27 (m, 1H, NCH2a), 2.98e2.88 (m, 1H,NCH2b), 2.36 (dt, 1H, J 8.7 & 17.6 Hz, CHCH2a), 2.25e2.13 (m, 1H,CHCH2b); 13C NMR (75 MHz, CDCl3); δ 173.10, 137.08, 129.17, 128.36,127.32, 64.40, 62.45, 51.83, 50.85, 21.72; HRMS m/z (ESI) 206.1198([M + H]+ requires 206.1175).
Reference: [1] Tetrahedron, 2012, vol. 68, # 22, p. 4117 - 4128
[2] Tetrahedron, 1989, vol. 45, # 10, p. 3089 - 3098
[3] Tetrahedron Asymmetry, 1998, vol. 9, # 3, p. 429 - 435
[4] Organic Letters, 2010, vol. 12, # 24, p. 5708 - 5711
[5] European Journal of Medicinal Chemistry, 2017, vol. 127, p. 671 - 690
  • 2
  • [ 124685-61-6 ]
  • [ 124619-68-7 ]
  • [ 18085-37-5 ]
  • [ 199620-14-9 ]
Reference: [1] Journal of the American Chemical Society, 1990, vol. 112, # 6, p. 2264 - 2273
  • 3
  • [ 24424-99-5 ]
  • [ 18085-37-5 ]
  • [ 255882-72-5 ]
Reference: [1] Organic Letters, 2006, vol. 8, # 19, p. 4335 - 4338
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 18085-37-5 ]

Aryls

Chemical Structure| 1137664-24-4

[ 1137664-24-4 ]

Ethyl 6-phenylpiperidine-2-carboxylate

Similarity: 0.85

Chemical Structure| 21319-53-9

[ 21319-53-9 ]

1-Benzylpiperidine-2-carboxylic acid

Similarity: 0.84

Chemical Structure| 1799439-16-9

[ 1799439-16-9 ]

(S)-Ethyl 2-(4-benzylmorpholin-3-yl)acetate

Similarity: 0.84

Chemical Structure| 91641-50-8

[ 91641-50-8 ]

2-Morpholino-2-phenylacetic acid hydrochloride

Similarity: 0.81

Chemical Structure| 75154-68-6

[ 75154-68-6 ]

(S)-Methyl 1-tritylaziridine-2-carboxylate

Similarity: 0.78

Esters

Chemical Structure| 191327-28-3

[ 191327-28-3 ]

(R)-Methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate

Similarity: 0.88

Chemical Structure| 57060-88-5

[ 57060-88-5 ]

Methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride

Similarity: 0.87

Chemical Structure| 78183-55-8

[ 78183-55-8 ]

(S)-Methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride

Similarity: 0.87

Chemical Structure| 1137664-24-4

[ 1137664-24-4 ]

Ethyl 6-phenylpiperidine-2-carboxylate

Similarity: 0.85

Chemical Structure| 1799439-16-9

[ 1799439-16-9 ]

(S)-Ethyl 2-(4-benzylmorpholin-3-yl)acetate

Similarity: 0.84

Related Parent Nucleus of
[ 18085-37-5 ]

Aliphatic Heterocycles

Chemical Structure| 1137664-24-4

[ 1137664-24-4 ]

Ethyl 6-phenylpiperidine-2-carboxylate

Similarity: 0.85

Chemical Structure| 21319-53-9

[ 21319-53-9 ]

1-Benzylpiperidine-2-carboxylic acid

Similarity: 0.84

Chemical Structure| 1799439-16-9

[ 1799439-16-9 ]

(S)-Ethyl 2-(4-benzylmorpholin-3-yl)acetate

Similarity: 0.84

Chemical Structure| 91641-50-8

[ 91641-50-8 ]

2-Morpholino-2-phenylacetic acid hydrochloride

Similarity: 0.81

Chemical Structure| 491833-36-4

[ 491833-36-4 ]

(S)-5-Phenylmorpholin-2-one hydrochloride

Similarity: 0.76

Azetidines

Chemical Structure| 53871-06-0

[ 53871-06-0 ]

Methyl 1-benzhydrylazetidine-3-carboxylate

Similarity: 0.71

Chemical Structure| 162698-26-2

[ 162698-26-2 ]

Methyl azetidine-2-carboxylate hydrochloride

Similarity: 0.70

Chemical Structure| 374791-02-3

[ 374791-02-3 ]

(R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)azetidine-2-carboxylic acid

Similarity: 0.66

Chemical Structure| 136552-06-2

[ 136552-06-2 ]

(S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)azetidine-2-carboxylic acid

Similarity: 0.66

Chemical Structure| 255882-72-5

[ 255882-72-5 ]

Methyl 1-Boc-azetidine-2-carboxylate

Similarity: 0.63